Regulon

Regulon: R-2588

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
251.6604610Pr-143Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1495 ENSG00000044115 CTNNA1 E5RGS1
23161 ENSG00000071189 SNX13 A0A087WUZ7
9689 ENSG00000082153 BZW1 Q7L1Q6
334 ENSG00000084234 APLP2 Q06481
3655 ENSG00000091409 ITGA6 P23229
3717 ENSG00000096968 JAK2 O60674
5216 ENSG00000108518 PFN1 P07737
3312 ENSG00000109971 HSPA8 A8K7Q2
50862 ENSG00000110315 RNF141 Q8WVD5
10114 ENSG00000110422 HIPK3 Q9H422
10728 ENSG00000110958 PTGES3 Q15185
55825 ENSG00000115425 PECR Q9BY49
5052 ENSG00000117450 PRDX1 Q06830
6272 ENSG00000134243 SORT1 Q99523
3936 ENSG00000136167 LCP1 P13796
7099 ENSG00000136869 TLR4 O00206
9180 ENSG00000145623 OSMR Q99650
1973 ENSG00000161960 EIF4A1 P60842
6565 ENSG00000163406 SLC15A2 Q16348
25932 ENSG00000169504 CLIC4 Q9Y696
4973 ENSG00000173391 OLR1 A0A024RAU0
3766 ENSG00000177807 KCNJ10 P78508
2760 ENSG00000196743 GM2A P17900
5660 ENSG00000197746 PSAP P07602
4067 ENSG00000254087 LYN P07948

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUXOLITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor41
PACRITINIBFLT3Small moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor30
IZENCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOFACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GANDOTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
RUXOLITINIB PHOSPHATEJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
PEFICITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
FORIGERIMODHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
LESTAURTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
AC-430JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
MOMELOTINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
NS-018JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
BARICITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
BMS-911543JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
JNJ-26483327ERBB2Small moleculeINHIBITORTyrosine-protein kinase FYN inhibitor10
UPADACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FEDRATINIB HYDROCHLORIDEJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
RESATORVIDTLR4Small moleculeINHIBITORToll-like receptor 4 inhibitor30
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
ZOTIRACICLIBCDK9Small moleculeINHIBITORCyclin-dependent kinase 9 inhibitor11
TOFACITINIB CITRATEJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FORIGERIMOD ACETATEHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOLIMIDONELYNSmall moleculePOSITIVE ALLOSTERIC MODULATORTyrosine-protein kinase Lyn positive allosteric modulator20
ERITORAN TETRASODIUMTLR4Small moleculeANTAGONISTToll-like receptor 4/MD-2 antagonist30
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
XL-019JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
AZD-1480JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DELGOCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
ERITORANTLR4Small moleculeANTAGONISTToll-like receptor 4/MD-2 antagonist30
AT-9283AURKBSmall moleculeINHIBITORTyrosine-protein kinase JAK3 inhibitor20
FEDRATINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2588

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs